Response by Hoque et al to Letter Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation"

Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006671. doi: 10.1161/CIRCOUTCOMES.120.006671. Epub 2020 May 7.

Authors

Laboni Hoque¹, David D McManus^{1

2}, Alok Kapoor^{1

2}

Affiliations

¹ Department of Medicine University of Massachusetts Medical School, Worcester, MA (L.H., D.D.M., A.K.).
² University of Massachusetts Memorial Health Care, Worcester, MA (D.D.M., A.K.).

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Oral
Anticoagulants / adverse effects
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / drug therapy
Blood Coagulation
Humans
Stroke* / diagnosis
Stroke* / drug therapy
Stroke* / prevention & control

Substances

Anticoagulants

Grants and funding